GlassScriptPhysician profile
Madisynn Noga
NPI 1780242511
$1,949.99
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27.38 · 2021: $1,319 · 2022: $323 · 2023: $206 · 2024: $74.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $280.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wardlow Enterprises | $1,200.00 | 2021 | |
| Kerecis Limited | $143.40 | 2022 | |
| Organogenesis INC. | $119.08 | 2021 | |
| Smith+Nephew, INC. | $111.61 | 2022-2024 | Collagenase Santyl, Pico, Grafix Pl |
| Paratek Pharmaceuticals, INC. | $88.92 | 2022-2024 | Nuzyra |
| Stryker Corporation | $66.53 | 2022-2023 | Augment Injectable |
| Treace Medical Concepts, INC. | $37.39 | 2024 | |
| Horizon Therapeutics Plc | $30.99 | 2022-2023 | Krystexxa |
| Coastal Medical Technologies LLC | $28.58 | 2023 | |
| Integra Lifesciences Corporation | $27.38 | 2020 | |
| Averitas Pharma INC. | $26.01 | 2023 | Qutenza |
| Nevro Corp. | $25.47 | 2022 | |
| Medtronic, INC. | $25.09 | 2023 | Intellis Adaptivestim |
| Kci USA, INC. | $19.54 | 2023 | V.A.C. Dermatac, Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madisynn Noga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.